Table of Contents 1 Varicella Live Vaccine Market Overview 1.1 Product Overview and Scope of Varicella Live Vaccine 1.2 Varicella Live Vaccine Segment by Type 1.2.1 Global Varicella Live Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Monovalent Varicella Vaccine 1.2.3 Combination Varicella Vaccine 1.3 Varicella Live Vaccine Segment by Application 1.3.1 Varicella Live Vaccine Sales Comparison by Application: 2020 VS 2026 1.3.2 Chickenpox Immunization 1.3.3 Herpes Zoster Immunization 1.3.4 Measles, Mumps, Rubella and Varicella (MMRV) Immunization 1.4 Global Varicella Live Vaccine Market Size Estimates and Forecasts 1.4.1 Global Varicella Live Vaccine Revenue 2015-2026 1.4.2 Global Varicella Live Vaccine Sales 2015-2026 1.4.3 Varicella Live Vaccine Market Size by Region: 2020 Versus 2026 2 Global Varicella Live Vaccine Market Competition by Manufacturers 2.1 Global Varicella Live Vaccine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Varicella Live Vaccine Revenue Share by Manufacturers (2015-2020) 2.3 Global Varicella Live Vaccine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Varicella Live Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Varicella Live Vaccine Market Competitive Situation and Trends 2.5.1 Varicella Live Vaccine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Varicella Live Vaccine Players (Opinion Leaders) 3 Varicella Live Vaccine Retrospective Market Scenario by Region 3.1 Global Varicella Live Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Varicella Live Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Varicella Live Vaccine Market Facts & Figures by Country 3.3.1 North America Varicella Live Vaccine Sales by Country 3.3.2 North America Varicella Live Vaccine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Varicella Live Vaccine Market Facts & Figures by Country 3.4.1 Europe Varicella Live Vaccine Sales by Country 3.4.2 Europe Varicella Live Vaccine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Varicella Live Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Varicella Live Vaccine Sales by Region 3.5.2 Asia Pacific Varicella Live Vaccine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Varicella Live Vaccine Market Facts & Figures by Country 3.6.1 Latin America Varicella Live Vaccine Sales by Country 3.6.2 Latin America Varicella Live Vaccine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Varicella Live Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Varicella Live Vaccine Sales by Country 3.7.2 Middle East and Africa Varicella Live Vaccine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Varicella Live Vaccine Historic Market Analysis by Type 4.1 Global Varicella Live Vaccine Sales Market Share by Type (2015-2020) 4.2 Global Varicella Live Vaccine Revenue Market Share by Type (2015-2020) 4.3 Global Varicella Live Vaccine Price Market Share by Type (2015-2020) 4.4 Global Varicella Live Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Varicella Live Vaccine Historic Market Analysis by Application 5.1 Global Varicella Live Vaccine Sales Market Share by Application (2015-2020) 5.2 Global Varicella Live Vaccine Revenue Market Share by Application (2015-2020) 5.3 Global Varicella Live Vaccine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Varicella Live Vaccine Business 6.1 Bio-Med Pvt. Limited 6.1.1 Corporation Information 6.1.2 Bio-Med Pvt. Limited Description, Business Overview and Total Revenue 6.1.3 Bio-Med Pvt. Limited Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Bio-Med Pvt. Limited Products Offered 6.1.5 Bio-Med Pvt. Limited Recent Development 6.2 Changchun BCHT Biotechnology 6.2.1 Changchun BCHT Biotechnology Varicella Live Vaccine Production Sites and Area Served 6.2.2 Changchun BCHT Biotechnology Description, Business Overview and Total Revenue 6.2.3 Changchun BCHT Biotechnology Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Changchun BCHT Biotechnology Products Offered 6.2.5 Changchun BCHT Biotechnology Recent Development 6.3 Emcure Pharmaceuticals 6.3.1 Emcure Pharmaceuticals Varicella Live Vaccine Production Sites and Area Served 6.3.2 Emcure Pharmaceuticals Description, Business Overview and Total Revenue 6.3.3 Emcure Pharmaceuticals Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Emcure Pharmaceuticals Products Offered 6.3.5 Emcure Pharmaceuticals Recent Development 6.4 GlaxoSmithKline 6.4.1 GlaxoSmithKline Varicella Live Vaccine Production Sites and Area Served 6.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue 6.4.3 GlaxoSmithKline Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 GlaxoSmithKline Products Offered 6.4.5 GlaxoSmithKline Recent Development 6.5 GC Pharma 6.5.1 GC Pharma Varicella Live Vaccine Production Sites and Area Served 6.5.2 GC Pharma Description, Business Overview and Total Revenue 6.5.3 GC Pharma Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 GC Pharma Products Offered 6.5.5 GC Pharma Recent Development 6.6 Merck & Co. Inc. 6.6.1 Merck & Co. Inc. Varicella Live Vaccine Production Sites and Area Served 6.6.2 Merck & Co. Inc. Description, Business Overview and Total Revenue 6.6.3 Merck & Co. Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Merck & Co. Inc. Products Offered 6.6.5 Merck & Co. Inc. Recent Development 6.7 Mitsubishi Tanabe Pharma 6.6.1 Mitsubishi Tanabe Pharma Varicella Live Vaccine Production Sites and Area Served 6.6.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue 6.6.3 Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Mitsubishi Tanabe Pharma Products Offered 6.7.5 Mitsubishi Tanabe Pharma Recent Development 6.8 Novo Medi Sciences 6.8.1 Novo Medi Sciences Varicella Live Vaccine Production Sites and Area Served 6.8.2 Novo Medi Sciences Description, Business Overview and Total Revenue 6.8.3 Novo Medi Sciences Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Novo Medi Sciences Products Offered 6.8.5 Novo Medi Sciences Recent Development 6.9 Sanofi 6.9.1 Sanofi Varicella Live Vaccine Production Sites and Area Served 6.9.2 Sanofi Description, Business Overview and Total Revenue 6.9.3 Sanofi Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Sanofi Products Offered 6.9.5 Sanofi Recent Development 6.10 Takeda Pharmaceutical Company Limited. 6.10.1 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Production Sites and Area Served 6.10.2 Takeda Pharmaceutical Company Limited. Description, Business Overview and Total Revenue 6.10.3 Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Takeda Pharmaceutical Company Limited. Products Offered 6.10.5 Takeda Pharmaceutical Company Limited. Recent Development 7 Varicella Live Vaccine Manufacturing Cost Analysis 7.1 Varicella Live Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Varicella Live Vaccine 7.4 Varicella Live Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Varicella Live Vaccine Distributors List 8.3 Varicella Live Vaccine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Varicella Live Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Varicella Live Vaccine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Varicella Live Vaccine by Type (2021-2026) 10.2 Varicella Live Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Varicella Live Vaccine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Varicella Live Vaccine by Application (2021-2026) 10.3 Varicella Live Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Varicella Live Vaccine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Varicella Live Vaccine by Region (2021-2026) 10.4 North America Varicella Live Vaccine Estimates and Projections (2021-2026) 10.5 Europe Varicella Live Vaccine Estimates and Projections (2021-2026) 10.6 Asia Pacific Varicella Live Vaccine Estimates and Projections (2021-2026) 10.7 Latin America Varicella Live Vaccine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Varicella Live Vaccine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Varicella Live Vaccine Sales (M Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Varicella Live Vaccine Sales (M Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Varicella Live Vaccine Market Size by Type (M Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Varicella Live Vaccine Manufacturers Covered in This Study Table 5. Global Varicella Live Vaccine Sales (M Doses) by Manufacturers (2015-2020) Table 6. Global Varicella Live Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Varicella Live Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Varicella Live Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Varicella Live Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020) Table 10. Manufacturers Varicella Live Vaccine Sales Sites and Area Served Table 11. Manufacturers Varicella Live Vaccine Product Types Table 12. Global Varicella Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Varicella Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Varicella Live Vaccine Players Table 16. Global Varicella Live Vaccine Sales (M Doses) by Region (2015-2020) Table 17. Global Varicella Live Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Varicella Live Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Varicella Live Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Varicella Live Vaccine Sales by Country (2015-2020) (M Doses) Table 21. North America Varicella Live Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Varicella Live Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Varicella Live Vaccine Sales by Country (2015-2020) (M Doses) Table 25. Europe Varicella Live Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Varicella Live Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Varicella Live Vaccine Sales by Region (2015-2020) (M Doses) Table 29. Asia Pacific Varicella Live Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Varicella Live Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Varicella Live Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Varicella Live Vaccine Sales by Country (2015-2020) (M Doses) Table 33. Latin America Varicella Live Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Varicella Live Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Varicella Live Vaccine Sales by Country (2015-2020) (M Doses) Table 37. Middle East and Africa Varicella Live Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Varicella Live Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Varicella Live Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Varicella Live Vaccine Sales (M Doses) by Type (2015-2020) Table 41. Global Varicella Live Vaccine Sales Share by Type (2015-2020) Table 42. Global Varicella Live Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Varicella Live Vaccine Revenue Share by Type (2015-2020) Table 44. Global Varicella Live Vaccine Price (USD/Dose) by Type (2015-2020) Table 45. Global Varicella Live Vaccine Sales (M Doses) by Application (2015-2020) Table 46. Global Varicella Live Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Varicella Live Vaccine Sales Growth Rate by Application (2015-2020) Table 48. Bio-Med Pvt. Limited Varicella Live Vaccine Corporation Information Table 49. Bio-Med Pvt. Limited Description and Business Overview Table 50. Bio-Med Pvt. Limited Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 51. Bio-Med Pvt. Limited Main Product Table 52. Bio-Med Pvt. Limited Recent Development Table 53. Changchun BCHT Biotechnology Varicella Live Vaccine Corporation Information Table 54. Changchun BCHT Biotechnology Corporation Information Table 55. Changchun BCHT Biotechnology Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 56. Changchun BCHT Biotechnology Main Product Table 57. Changchun BCHT Biotechnology Recent Development Table 58. Emcure Pharmaceuticals Varicella Live Vaccine Corporation Information Table 59. Emcure Pharmaceuticals Corporation Information Table 60. Emcure Pharmaceuticals Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 61. Emcure Pharmaceuticals Main Product Table 62. Emcure Pharmaceuticals Recent Development Table 63. GlaxoSmithKline Varicella Live Vaccine Corporation Information Table 64. GlaxoSmithKline Corporation Information Table 65. GlaxoSmithKline Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 66. GlaxoSmithKline Main Product Table 67. GlaxoSmithKline Recent Development Table 68. GC Pharma Varicella Live Vaccine Corporation Information Table 69. GC Pharma Corporation Information Table 70. GC Pharma Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 71. GC Pharma Main Product Table 72. GC Pharma Recent Development Table 73. Merck & Co. Inc. Varicella Live Vaccine Corporation Information Table 74. Merck & Co. Inc. Corporation Information Table 75. Merck & Co. Inc. Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 76. Merck & Co. Inc. Main Product Table 77. Merck & Co. Inc. Recent Development Table 78. Mitsubishi Tanabe Pharma Varicella Live Vaccine Corporation Information Table 79. Mitsubishi Tanabe Pharma Corporation Information Table 80. Mitsubishi Tanabe Pharma Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 81. Mitsubishi Tanabe Pharma Main Product Table 82. Mitsubishi Tanabe Pharma Recent Development Table 83. Novo Medi Sciences Varicella Live Vaccine Corporation Information Table 84. Novo Medi Sciences Corporation Information Table 85. Novo Medi Sciences Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 86. Novo Medi Sciences Main Product Table 87. Novo Medi Sciences Recent Development Table 88. Sanofi Varicella Live Vaccine Corporation Information Table 89. Sanofi Corporation Information Table 90. Sanofi Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 91. Sanofi Main Product Table 92. Sanofi Recent Development Table 93. Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Corporation Information Table 94. Takeda Pharmaceutical Company Limited. Corporation Information Table 95. Takeda Pharmaceutical Company Limited. Varicella Live Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 96. Takeda Pharmaceutical Company Limited. Main Product Table 97. Takeda Pharmaceutical Company Limited. Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Varicella Live Vaccine Distributors List Table 101. Varicella Live Vaccine Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Varicella Live Vaccine Sales (M Doses) Forecast by Type (2021-2026) Table 106. Global Varicella Live Vaccine Sales Market Share Forecast by Type (2021-2026) Table 107. Global Varicella Live Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Varicella Live Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Varicella Live Vaccine Sales (M Doses) Forecast by Application (2021-2026) Table 110. Global Varicella Live Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Varicella Live Vaccine Sales (M Doses) Forecast by Region (2021-2026) Table 112. Global Varicella Live Vaccine Sales Market Share Forecast by Region (2021-2026) Table 113. Global Varicella Live Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Varicella Live Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Varicella Live Vaccine Figure 2. Global Varicella Live Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Monovalent Varicella Vaccine Product Picture Figure 4. Combination Varicella Vaccine Product Picture Figure 5. Global Varicella Live Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 6. Chickenpox Immunization Figure 7. Herpes Zoster Immunization Figure 8. Measles, Mumps, Rubella and Varicella (MMRV) Immunization Figure 9. Global Varicella Live Vaccine Market Size 2015-2026 (US$ Million) Figure 10. Global Varicella Live Vaccine Sales Capacity (M Doses) (2015-2026) Figure 11. Global Varicella Live Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Varicella Live Vaccine Sales Share by Manufacturers in 2020 Figure 13. Global Varicella Live Vaccine Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Varicella Live Vaccine Revenue in 2019 Figure 15. Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Varicella Live Vaccine Sales Market Share by Region (2015-2020) Figure 17. Global Varicella Live Vaccine Sales Market Share by Region in 2019 Figure 18. Global Varicella Live Vaccine Revenue Market Share by Region (2015-2020) Figure 19. Global Varicella Live Vaccine Revenue Market Share by Region in 2019 Figure 20. North America Varicella Live Vaccine Sales Market Share by Country in 2019 Figure 21. North America Varicella Live Vaccine Revenue Market Share by Country in 2019 Figure 22. U.S. Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 23. U.S. Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 25. Canada Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Varicella Live Vaccine Sales Market Share by Country in 2019 Figure 27. Europe Varicella Live Vaccine Revenue Market Share by Country in 2019 Figure 28. Germany Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 29. Germany Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 31. France Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 33. U.K. Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 35. Italy Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 37. Russia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Varicella Live Vaccine Sales Market Share by Region in 2019 Figure 39. Asia Pacific Varicella Live Vaccine Revenue Market Share by Region in 2019 Figure 40. China Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 41. China Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 43. Japan Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 45. South Korea Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 47. India Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 49. Australia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 51. Taiwan Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 53. Indonesia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 55. Thailand Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 57. Malaysia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 59. Philippines Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 61. Vietnam Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Varicella Live Vaccine Sales Market Share by Country in 2019 Figure 63. Latin America Varicella Live Vaccine Revenue Market Share by Country in 2019 Figure 64. Mexico Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 65. Mexico Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 67. Brazil Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 69. Argentina Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Varicella Live Vaccine Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Varicella Live Vaccine Revenue Market Share by Country in 2019 Figure 72. Turkey Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 73. Turkey Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 75. Saudi Arabia Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Varicella Live Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 77. U.A.E Varicella Live Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Varicella Live Vaccine by Type (2015-2020) Figure 79. Sales Market Share of Varicella Live Vaccine by Type in 2019 Figure 80. Revenue Share of Varicella Live Vaccine by Type (2015-2020) Figure 81. Revenue Market Share of Varicella Live Vaccine by Type in 2019 Figure 82. Global Varicella Live Vaccine Sales Growth by Type (2015-2020) (M Doses) Figure 83. Global Varicella Live Vaccine Sales Market Share by Application (2015-2020) Figure 84. Global Varicella Live Vaccine Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Varicella Live Vaccine by Application (2015-2020) Figure 86. Global Revenue Share of Varicella Live Vaccine by Application in 2020 Figure 87. Bio-Med Pvt. Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Changchun BCHT Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Emcure Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. GC Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Novo Medi Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Takeda Pharmaceutical Company Limited. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Price Trend of Key Raw Materials Figure 98. Manufacturing Cost Structure of Varicella Live Vaccine Figure 99. Manufacturing Process Analysis of Varicella Live Vaccine Figure 100. Varicella Live Vaccine Industrial Chain Analysis Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Porter's Five Forces Analysis Figure 104. North America Varicella Live Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 105. North America Varicella Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Europe Varicella Live Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 107. Europe Varicella Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Latin America Varicella Live Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 109. Latin America Varicella Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Middle East and Africa Varicella Live Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 111. Middle East and Africa Varicella Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Asia Pacific Varicella Live Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 113. Asia Pacific Varicella Live Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Bottom-up and Top-down Approaches for This Report Figure 115. Data Triangulation Figure 116. Key Executives Interviewed

Bio-Med Pvt. Limited Changchun BCHT Biotechnology Emcure Pharmaceuticals GlaxoSmithKline GC Pharma Merck & Co. Inc. Mitsubishi Tanabe Pharma Novo Medi Sciences Sanofi Takeda Pharmaceutical Company Limited.